Clarity Pharmaceuticals (CU6) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CU6 Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising todayJune 18 at 10:57 PM | msn.comBell Potter says this ASX 200 stock can rise 100%+June 11, 2025 | msn.comThursday's HotCopper trends: Firefly hits brakes, Clarity DISCO results | June 5, 2025June 5, 2025 | msn.comClarity Pharmaceuticals’ 64Cu-SARTATE Outperforms Standard Imaging in Phase II TrialJune 4, 2025 | tipranks.comVanguard Group Reduces Stake in Clarity PharmaceuticalsJune 4, 2025 | tipranks.comFirst patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CTMay 29, 2025 | finance.yahoo.comGuess which ASX 200 stock is jumping 10% on big newsMay 29, 2025 | msn.comClarity Pharmaceuticals: First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CTMay 29, 2025 | finanznachrichten.deClarity Pharmaceuticals Issues New Equity Securities for Employee IncentiveMay 29, 2025 | tipranks.comClarity Pharmaceuticals Advances Phase III AMPLIFY Trial for Prostate Cancer ImagingMay 28, 2025 | tipranks.comClarity Pharmaceuticals: Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commencesMay 20, 2025 | finanznachrichten.deRegistrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commencesMay 20, 2025 | finance.yahoo.comHealth Check: There’s no Biden time as Clarity launches prostate cancer study aimed at early detectionMay 20, 2025 | msn.comClarity Pharmaceuticals Launches Phase III Trial for Prostate Cancer DiagnosticMay 19, 2025 | tipranks.comTrump executive order to hit these 3 ASX pharmaceutical stocksMay 14, 2025 | msn.com3 ASX Penny Stocks With Market Caps Larger Than A$500MMay 13, 2025 | finance.yahoo.comSECuRE trial update: First patient treated in the Phase II Cohort ExpansionApril 17, 2025 | morningstar.comClarity signs high-volume commercial-scale copper-64 Supply Agreement with NusanoApril 17, 2025 | gurufocus.comClarity scribes deal on delivery of copper 64 isotopesApril 17, 2025 | msn.comClarity Pharmaceuticals Secures Copper-64 Supply Agreement with NusanoApril 16, 2025 | tipranks.comClarity Pharmaceuticals: SECuRE trial update: First patient treated in the Phase II Cohort ExpansionApril 15, 2025 | finanznachrichten.deClarity Pharmaceuticals Advances SECuRE Trial with Enhanced Prostate Cancer TreatmentApril 14, 2025 | tipranks.comClarity Pharmaceuticals And 2 Other ASX Penny Stocks To WatchApril 14, 2025 | finance.yahoo.comVanguard Group Becomes Substantial Holder in Clarity PharmaceuticalsApril 10, 2025 | tipranks.comWhy is this ASX 200 healthcare share leaping 14% today?March 18, 2025 | msn.comClarity Pharmaceuticals Ltd. (CU6) Gets a Buy from Bell PotterMarch 13, 2025 | markets.businessinsider.comCanaccord Genuity Reaffirms Their Buy Rating on Clarity Pharmaceuticals Ltd. (CU6)March 7, 2025 | markets.businessinsider.comGuess which ASX 200 biotech stock is jumping 7% on big newsMarch 4, 2025 | msn.comClarity Pharmaceuticals Ltd Announces Quotation of New SecuritiesMarch 4, 2025 | tipranks.comClarity Pharmaceuticals Issues New Shares, Strengthening Market PositionMarch 4, 2025 | tipranks.comClarity Pharmaceuticals Secures Copper-64 Supply for Enhanced Cancer DiagnosticsMarch 4, 2025 | tipranks.comWhy is this ASX 200 healthcare share tanking 10% on Tuesday?March 3, 2025 | msn.comClarity Pharmaceuticals Reports Increased Loss but Stronger Asset BaseFebruary 28, 2025 | tipranks.comClarity Pharmaceuticals Reports Key 2025 Interim AchievementsFebruary 28, 2025 | tipranks.comAnother win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancerFebruary 19, 2025 | msn.comClarity Pharmaceuticals Secures FDA Fast Track for Prostate Cancer TreatmentFebruary 18, 2025 | tipranks.comClarity Pharmaceuticals’ 64Cu-SAR-bisPSMA Receives FDA Fast Track DesignationFebruary 17, 2025 | tipranks.comClarity Pharmaceuticals Issues New Shares Under Corporations Act ComplianceFebruary 10, 2025 | tipranks.comClarity Pharmaceuticals Advances Prostate Cancer Treatment with SECuRE Trial SuccessJanuary 31, 2025 | tipranks.comClarity Pharmaceuticals (ASX:CU6) Is In A Strong Position To Grow Its BusinessJanuary 30, 2025 | finance.yahoo.comClarity Pharmaceuticals’ Groundbreaking Diagnostic Achievements in Prostate CancerJanuary 27, 2025 | tipranks.comGuess which ASX 200 biotech stock is jumping 15% on big US FDA newsJanuary 24, 2025 | msn.comClarity Pharmaceuticals: Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancerJanuary 24, 2025 | finanznachrichten.deClarity jumps as FDA awards fast track status for PET scan imaging agentJanuary 24, 2025 | msn.comClarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical ...January 24, 2025 | gurufocus.comClarity Pharmaceuticals Secures FDA Fast Track for Prostate Cancer Imaging AgentJanuary 23, 2025 | tipranks.comThis fund returned 109% in 2024. Here are 2 of its best-performing ASX sharesJanuary 22, 2025 | msn.comClarity Pharmaceuticals Issues New Shares Without DisclosureJanuary 22, 2025 | tipranks.comThe scientist-turned-banker’s mission to fund cancer breakthroughJanuary 10, 2025 | afr.comClarity Pharmaceuticals Updates on Securities CessationJanuary 8, 2025 | tipranks.com Get Clarity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CU6 and its competitors with MarketBeat's FREE daily newsletter. Email Address CU6 Media Mentions By Week CU6 Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CU6 News Sentiment▼0.690.68▲Average Medical News Sentiment CU6 News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CU6 Articles This Week▼11▲CU6 Articles Average Week Get Clarity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CU6 and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AKRO News Today RYTM News Today ZLAB News Today PTCT News Today CYTK News Today RNA News Today KRYS News Today SRPT News Today MRUS News Today ACAD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CU6) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarity Pharmaceuticals Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Clarity Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
